摘要
为了在分离技术和生物分析中用稳定的合成材料取代生物大分子,开发了仿生受体和催化剂:功能单体与目标分析物一起聚合,模板去除后在类似抗体和酶活性位点的分子印迹聚合物(MIP)中形成空穴。从近80年前开始,2016年出版了大约1100篇关于MIPs的论文。电聚合允许直接在石英晶体微天平(QCM)和表面等离子体共振(SPR)的伏安电极或芯片上沉积MIPs。对于药物安培法MIPs的读出,微分脉冲伏安法(DPV)和阻抗谱(EIS)比QCM或SPR具有更高的灵敏度。应用简单的电化学器件,既可以重复制备MIP传感器,又可以实现敏感信号的产生。电化学MIP-传感器的整个药库,例如最常用的止痛药,抗生素和抗癌药物已经提出在文献和实验室条件下进行测试。这些仿生传感器通常有测量范围,包括较低的纳米到毫摩尔浓度范围,它们在极端pH和非水萃取物等有机溶剂中是稳定的。
关键词: 仿生传感器,分子印迹聚合物,药物传感器,药物印迹,电聚合,电化学传感器。
Current Medicinal Chemistry
Title:Electrochemical MIP-Sensors for Drugs
Volume: 25 Issue: 33
关键词: 仿生传感器,分子印迹聚合物,药物传感器,药物印迹,电聚合,电化学传感器。
摘要: In order to replace bio-macromolecules by stable synthetic materials in separation techniques and bioanalysis biomimetic receptors and catalysts have been developed: Functional monomers are polymerized together with the target analyte and after template removal cavities are formed in the ”molecularly imprinted polymer” (MIP) which resemble the active sites of antibodies and enzymes. Starting almost 80 years ago, around 1,100 papers on MIPs were published in 2016. Electropolymerization allows to deposit MIPs directly on voltammetric electrodes or chips for quartz crystal microbalance (QCM) and surface plasmon resonance (SPR). For the readout of MIPs for drugs amperometry, differential pulse voltammetry (DPV) and impedance spectroscopy (EIS) offer higher sensitivity as compared with QCM or SPR. Application of simple electrochemical devices allows both the reproducible preparation of MIP sensors, but also the sensitive signal generation. Electrochemical MIP-sensors for the whole arsenal of drugs, e.g. the most frequently used analgesics, antibiotics and anticancer drugs have been presented in literature and tested under laboratory conditions. These biomimetic sensors typically have measuring ranges covering the lower nano- up to millimolar concentration range and they are stable under extreme pH and in organic solvents like nonaqueous extracts.
Export Options
About this article
Cite this article as:
Electrochemical MIP-Sensors for Drugs, Current Medicinal Chemistry 2018; 25 (33) . https://dx.doi.org/10.2174/0929867324666171005103712
DOI https://dx.doi.org/10.2174/0929867324666171005103712 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Assessing Drugs for their Cardio-Toxicity
Letters in Drug Design & Discovery Lipid Resuscitation: A Life-Saving Antidote for Local Anesthetic Toxicity
Current Pharmaceutical Biotechnology Subclinical Thyroid Dysfunction and the Risk of Cardiovascular Disease
Current Pharmaceutical Design Utility of Anti-Arrhythmic Medications in ‘Lone Atrial Fibrillation’
Current Pharmaceutical Design Ascorbic Acid: Its Role in Immune System and Chronic Inflammation Diseases
Mini-Reviews in Medicinal Chemistry Editorial (Novel Therapies and Botanical and Mechanical Approaches for Management of Cardiovascular Disease)
Recent Patents on Cardiovascular Drug Discovery Pharmacogenetics and Anaesthesiology
Current Pharmacogenomics Ximelagatran - A Promising New Drug in Thromboembolic Disorders
Current Pharmaceutical Design Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
Current Signal Transduction Therapy Generating a Biological Pacemaker - Tackling Arrhythmias the Stem Cell Way
Recent Patents on Regenerative Medicine Potential Treatment of Cardiac Hypertrophy and Heart Failure by Inhibiting the Sarcolemmal Binding of Phospholipase Cβ1b
Current Drug Targets The Adult Patient with Eisenmenger Syndrome: A Medical Update After Dana Point Part I: Epidemiology, Clinical Aspects and Diagnostic Options
Current Cardiology Reviews Effectiveness and Safety of Digoxin on Chronic Heart Failure
Current Pharmaceutical Analysis Ranolazine and its Antiarrhythmic Actions
Cardiovascular & Hematological Agents in Medicinal Chemistry Redefining Cardiovascular (CV) Death as a Primary Endpoint Component in Cardiovascular Outcome Trials
Current Diabetes Reviews NLRP3 Is Involved in Ischemia/Reperfusion Injury
CNS & Neurological Disorders - Drug Targets Geriatric Psychopharmacology in Acute Settings
Current Psychopharmacology Hypertension in Pregnancy: Pathophysiology & Management Strategies
Current Pharmaceutical Design Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids
Medicinal Chemistry Macrolide Therapy Targets a Specific Phenotype in Respiratory Medicine: From Clinical Experience to Basic Science and Back
Inflammation & Allergy - Drug Targets (Discontinued)